Nobody agrees on how best to collect data about diseases that threaten human health. That looks set to change.
Fertility doctors used a controversial technique to create a single egg from two women’s DNA, fertilized it, and watched as it grew into a healthy baby.
The approach could be a tenth the price of earlier methods.
The medical maker collective Four Thieves Vinegar made an “EpiPencil” for a tiny fraction of what the EpiPen manufacturer Mylan charges.
For patients with some inherited diseases, a chance to test an experimental treatment can offer the only hope.
Mapping the 3-D network structure of a fly’s brain is a major step forward. But it took 1,700 person-hours to complete, meaning that human labor will be a significant bottleneck for future advances.
Can cell therapy help spinal-cord injury? A long-running study hopes the answer is yes.
Company pursues breakthrough medicines with proteins unlike any seen in nature.
But the technology for extinguishing species is dividing conservationists.
The blood-testing startup adds a flubbed test for the Zika virus to its rap sheet.